Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23 | Free Publication Certificate
updates
NAAS Rating: 5.23 new

Vol. 3, Issue 2 (2014)

Clinico-Pathogenetic Substantiation of Zinaxin-Based Periodontal Dressing Administration

Author(s):
S.S. Romanyshyn
Abstract:
Our investigations resulted in optimal adjustment of a medicinal agent for Zinaxin-based periodontal dressing. We developed two types of this drug formulation for patients suffering from generalized periodontitis with chronic and exacerbated course considering features of the clinical course. To detect an effective concentration of Zinaxin in the periodontal dressing used for local administration we examined 39 patients suffering from generalized periodontitis at the age of 35-44. Clinical and laboratory investigations showed an increase of gum fluid eicosanoids (prostaglandins and leukotrienes) of patients suffering from generalized periodontitis before treatment by contrast to patients with clinically healthy periodontium. We found out that Zinaxin-based periodontal dressing continued to be effective for about 12 hours, during which a positive decrease of gingival fluid eicosanoids was observed. As a result of a number of experimental dilutions of Zinaxin we detected that optimal concentration of this medication formulated into the periodontal dressing was 1:100.
Pages: 39-43  |  1347 Views  25 Downloads


The Pharma Innovation Journal
How to cite this article:
S.S. Romanyshyn . Clinico-Pathogenetic Substantiation of Zinaxin-Based Periodontal Dressing Administration. Pharma Innovation 2014;3(2):39-43.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal